Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nuclear matrix targets for anticancer agents.

D J Fernandes1, C V Catapano

  • 1Department of Biochemistry, Bowman Gray School of Medicine, Wake Forest University, Winston-Salem, North Carolina 27103.

Cancer Cells (Cold Spring Harbor, N.Y. : 1989)
|April 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Androgen-deprivation therapies for prostate cancer and risk of infection by SARS-CoV-2: a population-based study (N = 4532).

Annals of oncology : official journal of the European Society for Medical Oncology·2020
Same author

Phase I trial of the oral smoothened inhibitor sonidegib in combination with paclitaxel in patients with advanced solid tumors.

Investigational new drugs·2017
Same author

An analysis of response to neo-adjuvant chemotherapy in patients with locally advanced breast cancer with emphasis on pathological complete response.

Indian journal of cancer·2016
Same author

Selection of optimal combinations of target genes for therapeutic multi-gene silencing based on miRNA co-regulation.

Cancer gene therapy·2013
Same author

A rare case of primary Ewings sarcoma of the nasal bone.

Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India·2012
Same author

Aberrant expression of the neuronal-specific protein DCDC2 promotes malignant phenotypes and is associated with prostate cancer progression.

Oncogene·2012

Anticancer drugs target the nuclear matrix, a DNA framework in eukaryotic cells. Understanding these interactions reveals how these drugs work and how resistance develops.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Cancer Research

Background:

  • The nuclear matrix is a dynamic framework organizing DNA into functional units for replication and transcription.
  • Matrix-associated DNA and proteins are increasingly recognized as targets for anticancer agents.
  • DNA at matrix-bound sites exhibits an open conformation, making it susceptible to damage from radiation and alkylating agents.

Purpose of the Study:

  • To explore the interactions between anticancer agents and the nuclear matrix.
  • To elucidate the mechanisms of action and resistance for specific anticancer drugs targeting the nuclear matrix.
  • To provide insights into the therapeutic effects of anticancer agents by studying their nuclear matrix interactions.

Main Methods:

  • Review of existing evidence on anticancer agent interactions with the nuclear matrix.

Related Experiment Videos

  • Analysis of DNA conformation at matrix-bound replication and transcription sites.
  • Examination of drug mechanisms, including fludarabine phosphate's inhibition of DNA replication and VM-26/m-AMSA's interaction with nuclear matrix topoisomerase II.

    • Main Results:

    • Ionizing radiation and certain alkylating agents preferentially damage DNA in an open conformation at matrix-bound sites.
    • Fludarabine phosphate inhibits DNA replication by disrupting matrix-associated primer RNA and RNA-primed Okazaki fragments.
    • VM-26 and m-AMSA specifically interact with nuclear matrix topoisomerase II, with resistance linked to enzyme depletion.

    Conclusions:

    • The nuclear matrix serves as a critical target for various anticancer agents.
    • Understanding drug interactions with the nuclear matrix is key to deciphering their therapeutic effects and resistance mechanisms.
    • Further research into these interactions promises to enhance anticancer drug development and application.